ProfileGDS4814 / ILMN_2300970
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 96% 95% 94% 96% 95% 95% 95% 96% 96% 95% 96% 96% 95% 95% 96% 96% 95% 95% 96% 96% 96% 96% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)1013.4796
GSM780708Untreated after 4 days (C2_1)922.89995
GSM780709Untreated after 4 days (C3_1)778.76394
GSM780719Untreated after 4 days (C1_2)110196
GSM780720Untreated after 4 days (C2_2)931.7795
GSM780721Untreated after 4 days (C3_2)826.8395
GSM780710Trastuzumab treated after 4 days (T1_1)908.87195
GSM780711Trastuzumab treated after 4 days (T2_1)1215.1496
GSM780712Trastuzumab treated after 4 days (T3_1)1022.2896
GSM780722Trastuzumab treated after 4 days (T1_2)884.41595
GSM780723Trastuzumab treated after 4 days (T2_2)1107.3796
GSM780724Trastuzumab treated after 4 days (T3_2)1008.7296
GSM780713Pertuzumab treated after 4 days (P1_1)964.92595
GSM780714Pertuzumab treated after 4 days (P2_1)954.70895
GSM780715Pertuzumab treated after 4 days (P3_1)1012.6996
GSM780725Pertuzumab treated after 4 days (P1_2)1000.0196
GSM780726Pertuzumab treated after 4 days (P2_2)955.49295
GSM780727Pertuzumab treated after 4 days (P3_2)972.09695
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)105396
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)1123.3896
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)1143.0396
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)1162.0396
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)1002.9196